Zalmoxis Europska Unija - hrvatski - EMA (European Medicines Agency)

zalmoxis

molmed spa - alogenih t stanica genetski modificirani sa retrovirusni vektor kodiranje za skraćeni oblik ljudske nizak afinitet receptora faktora rasta živaca (Δlngfr) i herpes simplex virus timidin kinaze (hsv-tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - antineoplastična sredstva - zalmoksis je indiciran kao dodatna terapija u haploidentical hematopoetskih matičnih stanica (hsct) odraslih bolesnika s visokog rizika hematoloških malignih bolesti.

Virbagen Omega Europska Unija - hrvatski - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - rekombinantni omega interferon mačjeg podrijetla - Иммуностимуляторы, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. kod mačaka zaraženih virusom fiv, smrtnost je bila niska (5%) i nije bila pod utjecajem liječenja.

Advantan 1 mg/g krema Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

advantan 1 mg/g krema

leo pharma a/s, industriparken 55, ballerup, danska - metilprednizolonaceponat - krema - 1 mg/g - urbroj: 1 g kreme sadrži 1 mg metilprednizolonaceponata